Biro ́ AA, Holderith NB, Nusser Z (2006) Release probability-dependent
scaling of the postsynaptic responses at single hippocampal GABAergic
synapses. J Neurosci 26:12487–12496.
Celio MR, Heizmann CW (1981) Calcium-binding protein parvalbumin as
a neuronal marker. Nature 293:300 –302.
Celio MR, Baier W, Scha ̈rer L, de Viragh PA, Gerday C (1988) Monoclonal
antibodies directed against the calcium binding protein parvalbumin.
Cell Calcium 9:81– 86.
Cobb SR, Buhl EH, Halasy K, Paulsen O, Somogyi P (1995) Synchronization
of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378:75–78.
Drake CT, Milner TA (2002) Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 12:119 –136.
Fo ̈ldy C, Neu A, Jones MV, Soltesz I (2006) Presynaptic, activity-dependent
modulation of cannabinoid type 1 receptor-mediated inhibition of GABA
release. J Neurosci 26:1465–1469.
Fo ̈ldy C, Lee SY, Szabadics J, Neu A, Soltesz I (2007) Cell type-specific gating of
perisomatic inhibition by cholecystokinin. Nat Neurosci 10:1128 –1130.
Freund TF (2003) Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci 26:489 – 495.
Freund TF, Buzsa ́ki G (1996) Interneurons of the hippocampus. Hippocampus 6:347– 470.
Freund TF, Katona I (2007) Perisomatic inhibition. Neuron 56:33– 42.
Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids
in synaptic signaling. Physiol Rev 83:1017–1066.
Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa
H, Taketo MM, Watanabe M, Manabe T, Kano M (2004) Two distinct
classes of muscarinic action on hippocampal inhibitory synapses: M2- mediated direct suppression and M1/M3-mediated indirect suppression
through endocannabinoid signalling. Eur J Neurosci 19:2682–2692.
Galarreta M, Erde ́lyi F, Szabo ́ G, Hestrin S (2004) Electrical coupling among
irregular-spiking GABAergic interneurons expressing cannabinoid re- ceptors. J Neurosci 24:9770 –9778.
Gao Y, Bezchlibnyk YB, Sun X, Wang JF, McEwen BS, Young LT (2006)
Effects of restraint stress on the expression of proteins involved in synaptic vesicle exocytosis in the hippocampus. Neuroscience 141:1139 –1148.
Glickfeld LL, Scanziani M (2006) Distinct timing in the activity of
cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 9:807– 815.
Ha ́jos N, Papp EC, Acsa ́dy L, Levey AI, Freund TF (1998) Distinct interneuron
types express M2 muscarinic receptor immunoreactivity on their dendrites
or axon terminals in the hippocampus. Neuroscience 82:355–376.
Ha ́ jos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF
(2000) Cannabinoids inhibit hippocampal GABAergic transmission and
network oscillations. Eur J Neurosci 12:3239 –3249.
Harris KM, Marshall PE, Landis DMD (1985) Ultrastructural study of
cholecystokinin-immunoreactive cells and processes in area CA1 of the
rat hippocampus. J Comp Neurol 233:147–158.
Hefft S, Jonas P (2005) Asynchronous GABA release generates long-lasting
inhibition at a hippocampal interneuron-principal neuron synapse. Nat
Neurosci 8:1319 –1328.
Honer WG, Hu L, Davies P (1993) Human synaptic proteins with a heterogenous distribution in cerebellum and visual cortex. Brain Res 609:9 –20.
Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J, Hu L, Boulianne GL,
Luo Z, Trimble WS (1997) Cingulate cortex synaptic terminal proteins
and neural cell adhesion molecule in schizophrenia. Neuroscience
78:99 –110.
Karson MA, Whittington KC, Alger BE (2008) Cholecystokinin inhibits
endocannabinoid-sensitive hippocampal IPSPs and stimulates others.
Neuropharmacol 54:117–128.
Klausberger T, Marton LF, O'Neill J, Huck JH, Dalezios Y, Fuentealba P, Suen
WY, Papp E, Kaneko T, Watanabe M, Csicsvari J, Somogyi P (2005)
Complementary roles of cholecystokinin- and parvalbumin-expressing
GABAergic neurons in hippocampal network oscillations. J Neurosci
25:9782–9793.
Kosaka T, Kosaka K, Tateishi K, Hamaoka Y, Yanaihara N, Wu JY, Hama K
(1985) GABAergic neurons containing CCK-8-like and/or VIP-like im-
